source
- Novo announces layoff of 215 New Jersey staff as Bausch + Lomb trial misses endpointNovo Pharma said it will cut 215 positions at its Plainsboro, New Jersey facility, with the reductions slated to begin in February 2027. The move adds to a series of recent workforce reductions ac…
- Alterome reports early Phase 1 data for KRAS-targeted therapy in pancreatic, lung and colon cancersAlterome has unveiled preliminary Phase 1 data for its experimental KRAS-targeted therapy. The drug is designed to hit a spectrum of KRAS mutations that drive several solid tumours. The early stud…